DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 2.73% to $205.61 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,428.78 and the Dow Jones Industrial Average rising 1.03% to 52,747.32.
Biogen Inc. closed 6.42% below its 52-week high of $219.72, which the company achieved on June 29th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.29% to $266.73, Pfizer Inc. $(PFE)$ rose 2.35% to $25.25, and AbbVie Inc. $(ABBV)$ rose 2.45% to $263.20.
Trading volume (1.8 M) eclipsed its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.